Q/C Technologies, Inc. Cash and Cash Equivalents
Q/C Technologies, Inc. (QCLS) had Cash and Cash Equivalents of $307.61 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-12
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $307.61K.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $1.13M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $987.00K.
- 2025-03-31: Cash and Cash Equivalents, at Carrying Value $73.24K.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $307.61K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $1.13M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $987.00K 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $73.24K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $173.15K 10-K · filed 2026-04-15 | |
| 2024-09-30 | $1.19M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $536.03K 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $225.66K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $2.68M 10-K · filed 2025-04-11 | |
| 2023-09-30 | $298.32K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $93.82K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $188.55K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $749.09K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $309.93K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.12M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $1.19M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $555.97K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $1.38M 10-Q/A · filed 2021-11-15 | |
| 2021-06-30 | $2.13M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $569.37K 10-Q · filed 2021-05-18 | |
| 2020-12-31 | $148.28K 10-K · filed 2022-03-31 | $18.62M 10-K · filed 2021-03-01 |
| 2020-09-30 | $16.19M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $11.45M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $812.44K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $517.44K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $363.29K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $248.44K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $275.52K 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $181.75K 10-K · filed 2020-03-25 | |
| 2018-09-30 | $1.30M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $275.96K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $647.27K 10-Q · filed 2018-07-13 | |
| 2017-12-31 | $438.43K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $135.13K 10-Q/A · filed 2018-07-13 | |
| 2017-06-30 | $197.18K 10-Q/A · filed 2018-07-13 | |
| 2017-03-31 | $2.09M 10-Q · filed 2018-07-13 | |
| 2016-12-31 | $72.70K 10-Q/A · filed 2018-07-13 | |
| 2016-09-30 | $195.86K 10-Q/A · filed 2018-07-13 | |
| 2016-06-30 | $379.53K 10-Q/A · filed 2018-07-13 | |
| 2016-03-31 | $180.39K 10-Q · filed 2017-05-15 | |
| 2015-12-31 | $402.06K 10-Q/A · filed 2018-07-13 | |
| 2015-09-30 | $393.37K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $261.23K 10-Q · filed 2016-08-11 | |
| 2015-03-31 | $336.24K 10-Q · filed 2016-05-12 | |
| 2014-12-31 | $455.84K 10-K · filed 2017-04-11 | |
| 2014-09-30 | $642.51K 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $402.28K 10-Q · filed 2015-08-18 | |
| 2014-03-31 | $305.81K 10-Q · filed 2015-05-14 | |
| 2013-12-31 | $103.63K 10-K · filed 2016-03-30 | |
| 2013-09-30 | $681.24K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $1.55M 10-Q · filed 2014-08-12 | |
| 2013-03-31 | $521.50K 10-Q · filed 2014-05-14 | |
| 2012-12-31 | $633.02K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |